A tornado that damaged a Pfizer manufacturing facility in North Carolina is sparking concerns about worsening drug shortagesin U.S. hospitals and highlighting the vulnerability of the domestic supply chain.
Pfizer said its facility in Rocky Mount, N.C., makes nearly 25 percent of the company’s sterile injectable medicines used in U.S. hospitals. It sustained serious damage Wednesday by an EF-3 rated tornado, according to the National Weather Service.
Hospitals across the country are already seeing shortages of sterile injectable drugs, said Tom Kraus, vice president of government relations at the American Society of Health-System Pharmacists, and the tornado is likely to make that worse.
“There are already 300 drugs that were in shortage before today. And many of those were sterile injectable drugs and like the ones manufactured at this facility. So, we are already in a state of crisis with drug shortages and this, obviously, has the potential to contribute to that,” Kraus said.
But until the company details the extent of the damage and which drugs were affected, the specifics of any potential shortages aren’t clear.
Pfizer said it was still assessing the damage to determine the impact on production, but all staff were able to evacuate.
“We already have teams on the ground assessing the damage and supporting our colleagues, and we are working urgently to determine the best way to get back online as quickly as possible, while ensuring the safety of our people,” CEO Albert Bourla tweeted on Thursday.
The site is one of the largest sterile injectable facilities in the world, with more than 1.4 million square feet of manufacturing space, according to the company. It makes products like anesthesia, painkillers, therapeutics, anti-infectives and surgical muscle relaxants.
Part of the issue, Kraus said, is that there are only two or three manufacturers that make sterile injectable drugs because there isn’t a huge financial incentive for companies to enter that market.
“We do not have enough manufacturing capacity for these products, particularly sterile injectable drugs, and we don’t have a diversified manufacturing capacity for them,” Kraus said. “The fact that so much of these drugs are coming from one facility is a problem in and of itself” because there’s no redundancy when something goes wrong.”
Welcome to The Hill’s Health Care newsletter, we’re Nathaniel Weixel and Joseph Choi — every week we follow the latest moves on how Washington impacts your health.
Sen. Bernie Sanders (I-Vt.) is in a standoff with the White House over drug pricing, frustrating and confusing public health experts who worry his demands will stymie the Biden administration’s nominee to lead the National Institutes of Health (NIH).
Juul is seeking federal authorization for a new high-tech electronic cigarette that can electronically verify a user’s age and prevent the use of illicit counterfeit and unauthorized pod refills. Juul said the new device can connect to a web or smartphone app that uses third-party verification to ensure users are adults, and it includes features like device locking. The introduction of the new device comes as the company …
More than two years after federal hospital price transparency rules went into effect, only about a third of hospitals are currently in compliance, according to a report released this week. The nonprofit Patient Rights Advocate (PRA) released its fifth semi-annual report, which found that only 36 percent of 2,000 surveyed hospitals were in complete compliance with the rule. Since Jan. 1, 2021, hospitals have been required to …
Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services
LONDON (AP) — Thousands of senior doctors in England began a 48-hour walkout Thursday to demand better pay and conditions, paralyzing hospitals and leaving only emergency care covered. The severe disruptions are the latest in a wave of industrial action by public sector workers amid U.K.’s ongoing cost-of-living crisis. They come …
Prosecutors appear to be eyeing one unexpected charge as the Justice Department winds down its investigation into former President Trump’s effort to … Read more
